Progress in Clinical Research on Belimumab in the Treatment of Rheumatic Diseases
- 作者单位
- 山东第一医科大学附属省立医院风湿免疫科，山东 济南
- 刊名
- Advances in Clinical Medicine
- 年份
- 2024
- 卷号
- Vol.14 No.1
- 页码
- 1673-1683
- ISSN
- 2161-8712
- 摘要
- In recent years, with the continuous improvement of molecular targeted intervention, the applica-tion of biological agents in rheumatic diseases has become increasingly widespread. Belimumab is a recombinant humanized IgG1-λ monoclonal antibody, which selectively targets B lymphocyte stim-ulator . This article provides a review of belimumab and its current research status in the treatment of rheumatic diseases.
- 文献类型
- 期刊
- 浏览量
- 2
-
被引次数
相同作者单位文献
- [1] 刘保成;杨清锐;麻贞贞;刘东霞 . Research Progress on Tocilizumab in the Treatment of Connective Tissue Disease-Related Interstitial Lung Disease[J] Advances in Clinical Medicine 2024 . Vol.14 No.2 . 2814-2820 .
- [2] 刘保成;杨清锐;麻贞贞;刘东霞 . Research Progress of Zoledronic Acid in the Treatment of Osteoarthritis[J] Advances in Clinical Medicine 2024 . Vol.14 No.2 . 2821-2826 .
- [3] 刘保成;麻贞贞;白艳艳;刘 洁;杨清锐;刘东霞 . Report of 3 Cases of SjÖgren’s Syndrome with Central Nervous System Damage as the First Symptom and Review of the Literature[J] Advances in Clinical Medicine 2024 . Vol.14 No.2 . 3723-3730 .